These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 31853827)

  • 1. ACE Inhibitor Therapy Does Not Influence the Survival Outcomes of Patients with Colorectal Liver Metastases Following Liver Resection.
    Sanyal S; Alabraba E; Ibrahim H; Olaru A; Cameron I; Gomez D
    J Gastrointest Cancer; 2021 Mar; 52(1):106-112. PubMed ID: 31853827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synchronous Versus Metachronous Colorectal Liver Metastasis Yields Similar Survival in Modern Era.
    Wisneski AD; Jin C; Huang CY; Warren R; Hirose K; Nakakura EK; Corvera CU
    J Surg Res; 2020 Dec; 256():476-485. PubMed ID: 32798995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-platelet therapy does not influence the outcome of patients undergoing hepatic resection for colorectal liver metastases, an observational study.
    Boyd-Carson H; Irving G; Navarro AP; Cameron IC; Gomez DS;
    Int J Surg; 2018 May; 53():59-64. PubMed ID: 29555531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
    John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
    Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Time to Surgery of Colorectal Liver Metastases on Survival.
    Chen EY; Mayo SC; Sutton T; Kearney MR; Kardosh A; Vaccaro GM; Billingsley KG; Lopez CD
    J Gastrointest Cancer; 2021 Mar; 52(1):169-176. PubMed ID: 32086781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical review of the prognostic significance of pathological variables in patients undergoing resection for colorectal liver metastases.
    Gomez D; Zaitoun AM; De Rosa A; Hossaini S; Beckingham IJ; Brooks A; Cameron IC
    HPB (Oxford); 2014 Sep; 16(9):836-44. PubMed ID: 24617566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of tumour biology and tumour burden in determining outcome after hepatic resection for colorectal metastases.
    Gomez D; Morris-Stiff G; Toogood GJ; Lodge JP; Prasad KR
    HPB (Oxford); 2010 Mar; 12(2):84-93. PubMed ID: 20495651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases - the multicenter randomized controlled PUMP trial.
    Buisman FE; Homs MYV; Grünhagen DJ; Filipe WF; Bennink RJ; Besselink MGH; Borel Rinkes IHM; Bruijnen RCG; Cercek A; D'Angelica MI; van Delden OM; Donswijk ML; van Doorn L; Doornebosch PG; Emmering J; Erdmann JI; IJzerman NS; Grootscholten C; Hagendoorn J; Kemeny NE; Kingham TP; Klompenhouwer EG; Kok NFM; Koolen S; Kuhlmann KFD; Kuiper MC; Lam MGE; Mathijssen RHJ; Moelker A; Oomen-de Hoop E; Punt CJA; Te Riele WW; Roodhart JML; Swijnenburg RJ; Prevoo W; Tanis PJ; Vermaas M; Versleijen MWJ; Veuger FP; Weterman MJ; Verhoef C; Groot Koerkamp B
    BMC Cancer; 2019 Apr; 19(1):327. PubMed ID: 30953467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bevacizumab improves survival in patients with synchronous colorectal liver metastases provided the primary tumor is resected first.
    Lim C; Doussot A; Osseis M; Esposito F; Salloum C; Calderaro J; Tournigand C; Azoulay D
    Clin Transl Oncol; 2018 Oct; 20(10):1274-1279. PubMed ID: 29594943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the surgeon as a variable in long-term survival after liver resection for colorectal metastases.
    Giuliante F; Ardito F; Vellone M; Ranucci G; Federico B; Giovannini I; Nuzzo G
    J Surg Oncol; 2009 Dec; 100(7):538-45. PubMed ID: 19722234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical risk scores in the current era of neoadjuvant chemotherapy for colorectal liver metastases.
    Kumar R; Dennison AR; Robertson V; Jones MJ; Neal CP; Garcea G
    ANZ J Surg; 2018 Jan; 88(1-2):E16-E20. PubMed ID: 27621179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of margin status and neoadjuvant chemotherapy on survival, recurrence after liver resection for colorectal liver metastasis.
    Pandanaboyana S; White A; Pathak S; Hidalgo EL; Toogood G; Lodge JP; Prasad KR
    Ann Surg Oncol; 2015 Jan; 22(1):173-9. PubMed ID: 25084766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nodular regenerative hyperplasia (NRH) complicating oxaliplatin chemotherapy in patients undergoing resection of colorectal liver metastases.
    Morris-Stiff G; White AD; Gomez D; Cameron IC; Farid S; Toogood GJ; Lodge JP; Prasad KR
    Eur J Surg Oncol; 2014 Aug; 40(8):1016-20. PubMed ID: 24370284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence at surgical margin following hepatectomy for colorectal liver metastases is not associated with R1 resection and does not impact survival.
    Andreou A; Knitter S; Schmelzle M; Kradolfer D; Maurer MH; Auer TA; Fehrenbach U; Lachenmayer A; Banz V; Schöning W; Candinas D; Pratschke J; Beldi G
    Surgery; 2021 May; 169(5):1061-1068. PubMed ID: 33386128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival and Prognostic Factors of Colorectal Liver Metastases After Surgical and Nonsurgical Treatment.
    Lemke J; Cammerer G; Ganser J; Scheele J; Xu P; Sander S; Henne-Bruns D; Kornmann M
    Clin Colorectal Cancer; 2016 Dec; 15(4):e183-e192. PubMed ID: 27269232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resection of Colorectal Liver Metastasis: Prognostic Impact of Tumor Burden vs KRAS Mutational Status.
    Tsilimigras DI; Hyer JM; Bagante F; Guglielmi A; Ruzzenente A; Alexandrescu S; Poultsides G; Sasaki K; Aucejo F; Pawlik TM
    J Am Coll Surg; 2021 Apr; 232(4):590-598. PubMed ID: 33383214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of surgical margin on type of recurrence after liver resection for colorectal metastases: a single-center experience.
    Nuzzo G; Giuliante F; Ardito F; Vellone M; Giovannini I; Federico B; Vecchio FM
    Surgery; 2008 Mar; 143(3):384-93. PubMed ID: 18291260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laparoscopic liver resection compared to open approach in patients with colorectal liver metastases improves further resectability: Oncological outcomes of a case-control matched-pairs analysis.
    Montalti R; Berardi G; Laurent S; Sebastiani S; Ferdinande L; Libbrecht LJ; Smeets P; Brescia A; Rogiers X; de Hemptinne B; Geboes K; Troisi RI
    Eur J Surg Oncol; 2014 May; 40(5):536-544. PubMed ID: 24555996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective cohort study of statin therapy effect on resected colorectal liver metastases.
    Alabraba E; Ibrahim H; Olaru A; Cameron I; Gomez D; Group NHS
    World J Gastrointest Surg; 2020 Feb; 12(2):34-44. PubMed ID: 32128027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973).
    Goéré D; Pignon JP; Gelli M; Elias D; Benhaim L; Deschamps F; Caramella C; Boige V; Ducreux M; de Baere T; Malka D
    BMC Cancer; 2018 Aug; 18(1):787. PubMed ID: 30081865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.